883901-68-6 Usage
Description
5-bromo-2-ethenylpyrimidine is a chemical compound with the molecular formula C6H5BrN2. It is a substituted pyrimidine derivative that contains a bromine atom and an ethenyl group. 5-bromo-2-ethenylpyrimidine is known for its versatile properties and is often used as a building block in organic synthesis, particularly in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
5-bromo-2-ethenylpyrimidine is used as a building block for the synthesis of various biologically active compounds. Its unique structure allows it to be a potential candidate for drug development, particularly in the area of antiproliferative and anticancer activities.
Used in Organic Synthesis:
5-bromo-2-ethenylpyrimidine is used as a reagent in chemical reactions for the synthesis of a wide range of biologically active compounds. Its presence of a bromine atom and an ethenyl group makes it a valuable component in the creation of new molecules with potential therapeutic applications.
Overall, 5-bromo-2-ethenylpyrimidine plays an important role in medicinal chemistry and organic synthesis due to its diverse applications and the potential for developing new drugs and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 883901-68-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,3,9,0 and 1 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 883901-68:
(8*8)+(7*8)+(6*3)+(5*9)+(4*0)+(3*1)+(2*6)+(1*8)=206
206 % 10 = 6
So 883901-68-6 is a valid CAS Registry Number.
883901-68-6Relevant articles and documents
PYRIDAZINE DERIVATIVES AS RORC MODULATORS
-
Page/Page column 143, (2018/05/24)
Compounds of formula (I): (I) or pharmaceutical salts thereof, wherein m, n,, p, q A, B, Ri, R2, R3, R4, R5, R6and R7are as defined herein. Also disclosed are methods of making the compounds and using the compounds as RORs modulators for treatment of inflammatory diseases such as arthritis.
HETEROARYL OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 56; 57, (2016/07/05)
The present invention is directed to heteroaryl compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES
-
Page/Page column 51, (2015/02/19)
The invention relates to compounds of Formula (I) wherein X, Y, R1, R2, R3, R4 and R5 are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.
